A Study of Attitude and Knowledge of the Psychiatry Resident Doctors toward Clinician–Pharmaceutical Industry Interaction

Balhara, Yatan Pal Singh; Mathur, Shachi; Anand, Nikhilesh

doi:10.4103/0253-7176.96162

Cited by 3 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmaceutical companies, including the profit motive, may also play a role in advancing the use of particular antipsychotic medications. Previous literature has shown that interactions with representatives from pharmaceutical companies affect physicians' prescribing behavior and can likely contribute to irrational prescribing of the company's advertised medications (Balhara et al, 2012;Fickweiler et al, 2018;Workneh et al, 2018). As newer antipsychotic medications tend to belong to the SGA family (Li et al, 2016), this might preferentially favor the prescribing of SGAs, which would be consistent with the global trends that we are observing.…”

Section: Discussionsupporting

confidence: 79%

Attitudes to antipsychotics: a multi-site survey of Canadian psychiatry residents

Bahji

Bajaj

2018

JMHTEP

View full text Add to dashboard Cite

Purpose The purpose of this paper is to identify the training needs of the next generation of psychiatrists, and barriers in prescribing first-generation antipsychotics (FGAs), long-acting injectable (LAIs) antipsychotics and clozapine. Design/methodology/approach An electronic survey was sent to psychiatry residents (N= 75/288, 26 percent) at four Canadian residency programs in late December 2017. The survey was based on an instrument originally developed at the University of Cambridge and consisted of 31 questions in 10 content domains. Findings Nearly 80 percent of residents were aware that FGAs and second-generation antipsychotics (SGAs) have similar efficacy. However, extra-pyramidal symptoms and lack of training experience were the leading concerns associated with the prescribing of FGAs. Although over 90 percent of residents felt confident about initiating an oral SGA as a regular medication, only 40 percent did so with FGAs. Confidence with initiating LAIs and clozapine was 60 and 61 percent, respectively. Practical implications The survey highlights the need for better training in the use of FGAs, clozapine and LAIs. These medications can be effectively used in providing patients with the most appropriate evidence-based treatment options to improve treatment outcomes, while ensuring that these resources are not lost to the future generations of psychiatrists. Originality/value The survey may be the first of its kind to assess antipsychotic prescribing attitudes in Canadian psychiatry residents in multiple sites.

show abstract

Section: Discussionsupporting

confidence: 79%

Attitudes to antipsychotics: a multi-site survey of Canadian psychiatry residents

Bahji

Bajaj

2018

JMHTEP

View full text Add to dashboard Cite

show abstract

“…In addition, an individual's resolve to respond for even frivolous gifts is often undervalued. [ 5 14 15 16 17 18 ]…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, despite the MCI officially coming up with the guidelines, the average neighborhood doctor is unlikely to be aware of the existence of the rules and the type of reprimand or punishment he is likely to face in the event of a contravention. [ 5 6 7 8 9 10 11 12 13 ]…”

mentioning

confidence: 99%

A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India

2016

View full text Add to dashboard Cite

Background:The promotional activities by medical representatives (MRs) of the pharmaceutical companies can impact the prescribing pattern of doctors. Hence, the interaction between doctors and the pharmaceutical industry is coming under increasing scrutiny.Objective:The primary objective was to assess the attitude of the doctors toward the interaction with the MRs of the pharmaceutical company. The secondary objective was to assess the awareness of the doctors about regulations governing their interaction with the pharmaceutical company.Materials and Methods:This was a cross-sectional study. This study was carried out using a pretested questionnaire containing 10 questions between June and September 2014. The doctors working in the Dhanalakshmi Srinivasan Medical College and Hospital, Perambalur (Tamil Nadu) during the study period was included.Results:A total of 100 pretested questionnaires were distributed, and 81 doctors responded (response rate 81%). 37% doctors responded that they interacted with MR once a week whereas 25.9% told that they interact with MRs twice a month. About 69.1% doctors think that MR exaggerate the benefits of medicines and downplays the risks and contraindications of medicine(P = 0.000). 61.7% doctors think that MR has an impact on their prescribing (P = 0.000). 63% doctors stated that they had received promotional tools such as stationery items, drug sample, textbooks or journal reprints from MR in last 12 months (P = 0.0012). Unfortunately, 70.4% doctors have not read the guidelines about interacting with the pharmaceutical industry or its representative (P = 0.000).Conclusion:Rather than forbidding any connection between doctors and industry, it is better to establish ethical guidelines. The Medical Council of India code is a step in the right direction, but the majority of doctors in this study have not read the guidelines about interacting with the pharmaceutical industry or its representative.

show abstract

“…While 58% reported being aware of Medical Council of India guidelines for the regulation of physician-industry interactions, only 35% believed there should actually be some external regulation of interactions between a psychiatrist and a pharmaceutical company. 52 Results from a second survey of Indian interns and residents were somewhat different. Three-quarters stated that they had never actively sought a gift or service from a sales representative or a pharmaceutical company, but more than 80% had received pens and pads and almost 30% had received books.…”

Section: Exposure Of Students and Doctors In Training To Promotion Education About Promotion And Attitudes Toward Promotionmentioning

confidence: 94%

Drug Promotion in India Since 2000: Problems Remain

Lexchin

2020

Int J Health Serv

View full text Add to dashboard Cite

Pharmaceutical companies engage heavily in promoting their products worldwide, and India is no exception. This article begins with an analysis of the therapeutic value of medications on the Indian market because, by definition, if a drug has no therapeutic value or has a negative benefit-to-harm ratio, then any promotion of that drug is inappropriate. It then examines 2 Indian case studies: drug promotion in Mumbai and the misuse of the World Health Organization logo in promotion. Next it describes specific types of promotion: advertisements in medical journals, brochures, and pamphlets; the actions of sales representatives; and the content of continuing medical education courses and medical conferences. The next sections examine medical students’ and trainees’ exposure to promotion and their attitudes about promotion; the attitudes of doctors about their interactions with the pharmaceutical industry; and whether promotion has an influence on prescribing. The article concludes with a critique of the existing industry, professional, and government regulatory regimes in India.

show abstract

A Study of Attitude and Knowledge of the Psychiatry Resident Doctors toward Clinician–Pharmaceutical Industry Interaction

Cited by 3 publications

References 15 publications

Attitudes to antipsychotics: a multi-site survey of Canadian psychiatry residents

Attitudes to antipsychotics: a multi-site survey of Canadian psychiatry residents

A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India

Drug Promotion in India Since 2000: Problems Remain

Contact Info

Product

Resources

About